Australia markets closed

Leap Therapeutics, Inc. (LPTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.7800-0.1300 (-4.47%)
At close: 04:00PM EDT
2.7990 +0.02 (+0.68%)
After hours: 07:04PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 106.38M
Enterprise value 35.99M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)160.10
Price/book (mrq)1.77
Enterprise value/revenue -66.81
Enterprise value/EBITDA 0.47

Trading information

Stock price history

Beta (5Y monthly) 0.54
52-week change 3-38.22%
S&P500 52-week change 326.27%
52-week high 310.2000
52-week low 31.2350
50-day moving average 32.7859
200-day moving average 32.5170

Share statistics

Avg vol (3-month) 3304.22k
Avg vol (10-day) 3173.92k
Shares outstanding 538.26M
Implied shares outstanding 638.26M
Float 819.85M
% held by insiders 115.88%
% held by institutions 126.68%
Shares short (30 Apr 2024) 41.36M
Short ratio (30 Apr 2024) 42.67
Short % of float (30 Apr 2024) 44.23%
Short % of shares outstanding (30 Apr 2024) 43.56%
Shares short (prior month 28 Mar 2024) 41.14M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 321 June 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-75.03%
Return on equity (ttm)-136.82%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -85.92M
Net income avi to common (ttm)-81.41M
Diluted EPS (ttm)-3.9800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)70.64M
Total cash per share (mrq)2.76
Total debt (mrq)262k
Total debt/equity (mrq)0.44%
Current ratio (mrq)5.64
Book value per share (mrq)2.35

Cash flow statement

Operating cash flow (ttm)-43.75M
Levered free cash flow (ttm)-46.85M